Dysregulating ClpP: From Antibiotics to Anticancer?

David A Dougan1, Ingo Hantke2, Kürşad Turgay2

  • 1La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC 3086, Australia.

Cell Chemical Biology
|August 18, 2018
PubMed

Insights

Researchers identified key mitochondrial protease regulators that trigger programmed cell death. These findings open new possibilities for developing innovative cancer therapeutics.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Mitochondrial proteases play crucial roles in cellular homeostasis.
  • Caseinolytic protease P (ClpP) is a key mitochondrial protease involved in protein degradation and quality control.

Purpose of the Study:

  • To identify novel dysregulators of the mitochondrial protease casein lytic protease P (ClpP).
  • To explore the potential of these dysregulators as therapeutic targets for cancer treatment.

Main Methods:

  • High-throughput screening assays to identify ClpP modulators.
  • Cell-based assays to assess the impact of dysregulators on programmed cell death.
  • Analysis of molecular pathways involved in ClpP regulation and cell death.

Main Results:

  • Several novel dysregulators of ClpP were identified.
  • These dysregulators were shown to induce programmed cell death in cancer cells.
  • The study provides a mechanistic link between ClpP dysregulation and cell death pathways.

Conclusions:

  • Dysregulators of casein lytic protease P (ClpP) represent a promising new class of compounds.
  • Targeting ClpP dysregulation offers a potential strategy for novel cancer therapeutics.
  • Further research into these dysregulators could lead to the development of effective cancer treatments.

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
60.0K
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.2K
Types of Genetic Transfer Between Organisms02:18

Types of Genetic Transfer Between Organisms

Genetic transfer occurs when genetic information is passed from one organism to another. It occurs via two mechanisms: vertical gene transfer and horizontal gene transfer. Vertical gene transfer occurs when genetic information is transferred from one generation to the next, which happens much more frequently than horizontal gene transfer. Both sexual and asexual reproduction are forms of vertical gene transfer, where one or more organisms pass some or all of their genome onto their progeny.
30.9K
The Roles of Bacteria and Fungi in Plant Nutrition02:11

The Roles of Bacteria and Fungi in Plant Nutrition

Plants have the impressive ability to create their own food through photosynthesis. However, plants often require assistance from organisms in the soil to acquire the nutrients they need to function correctly. Both bacteria and fungi have evolved symbiotic relationships with plants that help the species to thrive in a wide variety of environments.
47.4K
Bacterial Transformation01:33

Bacterial Transformation

In 1928, bacteriologist Frederick Griffith worked on a vaccine for pneumonia, which is caused by Streptococcus pneumoniae bacteria. Griffith studied two pneumonia strains in mice: one pathogenic and one non-pathogenic. Only the pathogenic strain killed host mice.
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
60.1K